Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Lung Cell Mol Physiol ; 310(11): L1088-97, 2016 06 01.
Article in English | MEDLINE | ID: mdl-27036867

ABSTRACT

The SU5416 + hypoxia (SuHx) rat model is a commonly used model of severe pulmonary arterial hypertension. While it is known that exposure to hypoxia can be replaced by another type of hit (e.g., ovalbumin sensitization) it is unknown whether abnormal pulmonary blood flow (PBF), which has long been known to invoke pathological changes in the pulmonary vasculature, can replace the hypoxic exposure. Here we studied if a combination of SU5416 administration combined with pneumonectomy (PNx), to induce abnormal PBF in the contralateral lung, is sufficient to induce severe pulmonary arterial hypertension (PAH) in rats. Sprague Dawley rats were subjected to SuPNx protocol (SU5416 + combined with left pneumonectomy) or standard SuHx protocol, and comparisons between models were made at week 2 and 6 postinitiation. Both SuHx and SuPNx models displayed extensive obliterative vascular remodeling leading to an increased right ventricular systolic pressure at week 6 Similar inflammatory response in the lung vasculature of both models was observed alongside increased endothelial cell proliferation and apoptosis. This study describes the SuPNx model, which features severe PAH at 6 wk and could serve as an alternative to the SuHx model. Our study, together with previous studies on experimental models of pulmonary hypertension, shows that the typical histopathological findings of PAH, including obliterative lesions, inflammation, increased cell turnover, and ongoing apoptosis, represent a final common pathway of a disease that can evolve as a consequence of a variety of insults to the lung vasculature.


Subject(s)
Hypertension, Pulmonary/pathology , Animals , Blood Pressure , Disease Models, Animal , Hypertension, Pulmonary/etiology , Indoles , Male , Pneumonectomy , Pyrroles , Rats, Sprague-Dawley
2.
Eur Respir J ; 36(4): 800-7, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20351034

ABSTRACT

Pulmonary arterial hypertension (PAH) still cannot be cured, warranting the search for novel treatments. Fasudil (a Rho kinase inhibitor) was compared with bosentan (an endothelin receptor blocker) and sildenafil (a phosphodiesterase 5 inhibitor), with emphasis on right ventricular (RV) function, in a reversal rat model of monocrotaline (MCT)-induced PAH. In addition, the effects of combining bosentan or sildenafil with fasudil were studied. MCT (40 mg·kg body weight(-1)) induced clear PAH in male Wistar rats (n = 9). After 28 days, echocardiography, RV catheterisation and histochemistry showed that cardiac frequency, stroke volume and RV contractility had deteriorated, accompanied by RV dilatation and hypertrophy, and marked pulmonary arterial wall thickening. Mean pulmonary arterial pressure and pulmonary vascular resistance increased significantly compared to healthy rats (n = 9). After 14 days, MCT-treated rats received a 14-day oral treatment with bosentan, sildenafil, fasudil or a combination of fasudil with either bosentan or sildenafil (all n = 9). All treatments preserved cardiac frequency, stroke volume and RV contractility, and reduced pulmonary vascular resistance and RV dilatation. Fasudil lowered RV systolic pressure and mean pulmonary arterial pressure significantly, by reducing pulmonary arterial remodelling, which reduced RV hypertrophy. Combining bosentan or sildenafil with fasudil had no synergistic effect. Fasudil significantly improved PAH, to a greater degree than did bosentan and sildenafil.


Subject(s)
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , Antihypertensive Agents/pharmacology , Monocrotaline/adverse effects , Piperazines/pharmacology , Sulfonamides/pharmacology , Sulfones/pharmacology , Vasodilator Agents/pharmacology , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Administration, Oral , Animals , Blood Pressure , Bosentan , Familial Primary Pulmonary Hypertension , Heart Ventricles/drug effects , Hemodynamics , Hypertension, Pulmonary/drug therapy , Hypertrophy, Right Ventricular/pathology , Pulmonary Artery/pathology , Purines/pharmacology , Rats , Sildenafil Citrate
3.
Circulation ; 120(1): 42-9, 2009 Jul 07.
Article in English | MEDLINE | ID: mdl-19546388

ABSTRACT

BACKGROUND: Exercise training in pulmonary arterial hypertension (PH) is a promising adjunct to medical treatment. However, it is still unclear whether training is beneficial for all PH patients. We hypothesized that right ventricular adaptation plays a pivotal role in the response to training. METHODS AND RESULTS: Two different dosages of monocrotaline were used in rats to model stable PH with preserved cardiac output and progressive PH developing right heart failure. Two weeks after injection, PH was confirmed by echocardiography, and treadmill training was initiated. Rats were trained for 4 weeks unless manifest right heart failure developed earlier. At the end of the study protocol, all rats were functionally assessed by endurance testing, echocardiography, and invasive pressure measurements. Lungs and hearts were further analyzed in quantitative histomorphologic analyses. In stable PH, exercise training was well tolerated and markedly increased exercise endurance (from 25+/-3.9 to 62+/-3.9 minutes; P<0.001). Moreover, capillary density increased significantly (from 1.21+/-0.12 to 1.51+/-0.07 capillaries per cardiomyocyte; P<0.05). However, in progressive PH, exercise training worsened survival (hazard ratio, 2.7; 95% confidence interval, 1.1 to 14.2) and increased pulmonary vascular remodeling. In addition, training induced widespread leukocyte infiltration into the right ventricle (from 135+/-14 to 276+/-18 leukocytes per 1 mm(2); P<0.001). CONCLUSIONS: In our rat model, exercise training was found to be beneficial in stable PH but detrimental in progressive PH. Future studies are necessary to address the clinical implications of our findings.


Subject(s)
Adaptation, Physiological/physiology , Heart Failure/physiopathology , Heart Failure/therapy , Hypertension, Pulmonary/physiopathology , Hypertension, Pulmonary/therapy , Physical Conditioning, Animal/physiology , Animals , Biopsy , Capillaries/physiology , Cardiac Catheterization , Cardiac Output/physiology , Coronary Circulation/physiology , Disease Models, Animal , Disease Progression , Echocardiography , Heart Failure/diagnosis , Hypertension, Pulmonary/chemically induced , Male , Monocrotaline/toxicity , Myocarditis/physiopathology , Physical Endurance/physiology , Rats , Rats, Wistar , Rest , Survival Rate
4.
Pflugers Arch ; 455(5): 951-9, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17912547

ABSTRACT

Implantable radio-telemetry methodology, allowing for continuous recording of pulmonary haemodynamics, has previously been used to assess effects of therapy on development and treatment of pulmonary hypertension. In the original procedure, rats were subjected to invasive thoracic surgery, which imposes significant stress that may disturb critical aspects of the cardiovascular system and delay recovery. In the present study, we describe and compare the original trans-thoracic approach with a new, simpler trans-diaphragm approach for catheter placement, which avoids the need for surgical invasion of the thorax. Satisfactory overall success rates up to 75% were achieved in both approaches, and right ventricular pressures and heart and respiratory rates normalised within 2 weeks. However, recovery was significantly faster in trans-diaphragm than in trans-thoracic operated animals (6.4+/-0.5 vs 9.5+/-1.1 days, respectively; p<0.05). Stable right ventricular pressures were recorded for more than 4 months, and pressure changes, induced by monocrotaline or pulmonary embolisms, were readily detected. The data demonstrate that right ventricular telemetry is a practicable procedure and a useful tool in pulmonary hypertension research in rats, especially when used in combination with echocardiography. We conclude that the described trans-diaphragm approach should be considered as the method of choice, for it is less invasive and simpler to perform.


Subject(s)
Hypertension, Pulmonary/physiopathology , Monitoring, Physiologic/methods , Pulmonary Artery/physiology , Telemetry/methods , Ventricular Pressure/physiology , Animals , Blood Pressure/physiology , Cardiac Output/physiology , Diaphragm , Electrodes, Implanted , Hypertension, Pulmonary/diagnosis , Male , Monitoring, Physiologic/instrumentation , Rats , Rats, Wistar , Telemetry/instrumentation , Ventricular Function, Right/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...